Source: Brazilian Journal of Infectious Diseases. Unidades: FM, FMRP
Subjects: HEPATITE C (TERAPIA), INTERFERONS, INFECÇÕES OPORTUNISTAS, HEPATITE CRÔNICA (TERAPIA), ANITIVIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Paulo Roberto Abrão et al. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, v. 19, n. 1, p. 15-22, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.bjid.2014.08.002. Acesso em: 17 nov. 2024.APA
Ferreira, P. R. A., Silva, M. H. da, Brandão-Melo, C. E., Rezende, R. E., Gonzalez, M., Reuter, T., et al. (2015). The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study. Brazilian Journal of Infectious Diseases, 19( 1), 15-22. doi:10.1016/j.bjid.2014.08.002NLM
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002Vancouver
Ferreira PRA, Silva MH da, Brandão-Melo CE, Rezende RE, Gonzalez M, Reuter T, Urbaez JD, Gianini RJ, Martinelli A, Mendes-Corrêa MC. The clinical effectiveness of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in HIV-infected patients in Brazil: a multicentric study [Internet]. Brazilian Journal of Infectious Diseases. 2015 ; 19( 1): 15-22.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1016/j.bjid.2014.08.002
